Drug Database
CA

calcium carbonate + vitamin D3 (Ideos)

✓ Approved

Innothera · VDR · 小分子

什么是 calcium carbonate + vitamin D3?

calcium carbonate + vitamin D3 是一种小分子,由Innothera研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名Ideos
公司Innothera
药物类别小分子
分子靶点VDR
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

calcium carbonate + vitamin D3 作用于 1 个分子靶点:

VDRvitamin D receptor (NR1I1, PPP1R163)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

calcium carbonate + vitamin D3 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Musculoskeletal and connective tissue disordersOsteoporosis✓ Approved

相关研究文献

PubMedBMC pregnancy and childbirth2026-11-19

Increased number of cells in day 3 embryosis associated with higher live birth rate in D5 vitrified-thawed single blastocyst transfer cycles.

Zheng Weiwei W, Lin Sheng S, He Yichao Y, Han Lu L et al.

Cell number in 3-day-old (D3) embryos influences pregnancy outcomes in patients undergoing cleavage-stage embryo transfer. However, the association between D3 cell number and pregnancy outcomes following 5-day-old (D5) vitrified-thawed single blastocyst transfer remains underexplored. This retrospective cohort follow-up study included 2035 cycles of D5 vitrified-thawed single blastocyst transfer. Patients were divided into six groups according to D3 embryo cell number: ≤5, 6, 7, 8, 9, and ≥ 10. Live birth rate (LBR), clinical pregnancy rate, miscarriage rate, and neonatal outcomes were compared across the groups. Statistical analyses were conducted using a multivariate logistic regression model. Furthermore, mediation analysis was performed to explore the association between D3 embryo cell number and LBR. LBR markedly increased with the D3 embryo cell number (p < 0.001). Subgroup analysis of high- and low-quality blastocysts also revealed significant differences in LBR across the groups (p < 0.05). Conversely, the miscarriage rate markedly decreased as the D3 embryo cell number increased (p < 0.05). The D3 embryo cell number and perinatal outcomes did not show an association. Compared with the 8-cell group, the ≤ 5-cell group had significantly lower LBR [aOR: 0.681, 95% confidence intervals (CI): 0.468-0.991, p < 0.05], whereas the ≥ 10-cell group had a significantly higher LBR (aOR: 1.632, 95% CI: 1.214-2.159, p < 0.01). Mediation analysis revealed that D3 embryo cell number provides unique prognostic information for live birth outcomes beyond blastocyst quality metrics. Furthermore, the inclusion of D3 embryo cell number improved the predictive performance of the ROC model (ΔAUC = 0.012, 95% CI: 0.004-0.023, p = 0.007). D3 embryo cell number is a valuable supplementary indicator for selecting D5 blastocysts in vitrified-thawed single blastocyst transfer cycles. Among blastocysts with comparable morphological quality, those derived from fast-cleaving D3 embryos were associated with a lower miscarriage rate and a higher likelihood of live birth, specifically when transferring lower-quality blastocysts.

PMID 43052792
阅读全文 →
PubMedJournal of orthopaedic surgery and research2026-11-19

Vitamin D in spine disorders: mechanisms, clinical evidence, and translational gaps-a narrative review.

Zhang Feng F, Bai Yun Y

Vitamin D has been increasingly implicated in the pathophysiology of spine disorders, yet its clinical utility remains uncertain. Across a broad spectrum of conditions, including intervertebral disc degeneration, chronic low back pain, lumbar spinal stenosis, spinal deformities, and surgical populations, vitamin D deficiency is highly prevalent. Mechanistically, vitamin D exerts pleiotropic effects through the vitamin D receptor, regulating inflammatory signaling, extracellular matrix homeostasis, oxidative stress, and ferroptosis, while also influencing paraspinal muscle biology, and genetic studies suggest that vitamin D receptor polymorphisms may contribute to inter-individual variability in disease susceptibility and cellular response. Despite strong biological plausibility and consistent observational associations, clinical evidence remains heterogeneous. In degenerative and pain-related conditions, randomized trials and meta-analyses do not demonstrate a consistent benefit of supplementation for pain relief or disease modification in unselected populations. In contrast, perioperative spine settings provide more promising findings, with deficiency associated with delayed fusion, poorer functional outcomes, and higher complication risk, while supplementation may improve intermediate-term recovery in selected patients. Across specific conditions such as lumbar spinal stenosis, adolescent idiopathic scoliosis, and axial spondyloarthritis, results remain inconsistent, and current evidence does not support routine supplementation for disease modification. Similarly, although low vitamin D levels are associated with increased risk of osteoporotic vertebral fractures, supplementation has not consistently improved fracture-related outcomes. Overall, vitamin D is best considered a modifiable comorbidity rather than a primary therapeutic target, and a targeted approach focused on deficient or high-risk individuals, particularly in perioperative contexts, appears more appropriate than universal supplementation. Future research should prioritize well-designed trials in deficient populations and precision-based strategies to clarify its role in spine care.

PMID 43053138
阅读全文 →
PubMedCritical care (London, England)2026-11-19

Effect of megadose vitamin C in patients with sepsis: the CEMVIS randomized clinical trial.

Guan Jianbin J, Wang Guizhong G, Liang Zhihui Z, Peng Wei W et al.

Previous randomized trials of vitamin C in sepsis have reported conflicting findings, but whether the effect of vitamin C varies according to septic shock status remains unclear. We aimed to evaluate the effect of megadose vitamin C in sepsis and explore whether treatment effect differed according to septic shock status. CEMVIS was a multicenter, randomized, single-blind, placebo-controlled trial conducted in four tertiary hospitals in China. Adults meeting Sepsis-3 criteria were randomly assigned (1:1) to receive intravenous vitamin C (12 g every 12 h for 4 days) or placebo using stratified randomization according to septic shock status. Patients were analyzed according to the modified intention-to-treat principle. The primary outcome was 28-day mortality. Between Feb 8, 2022, and Dec 25, 2024, 114 patients in the vitamin C group and 117 in the placebo group were included in the modified intention-to-treat population. 28-day mortality did not differ significantly between groups (35/114 [30.7%] vs 36/116 [31.0%]; odds ratio 0.99, 95% CI 0.56-1.74; p = 0.97). No significant differences were observed in the duration of mechanical ventilation, vasopressor therapy, and renal replacement therapy, or in changes in SOFA scores over 96 hours. Prespecified subgroup analyses showed significant interaction according to septic shock status (P for interaction = 0.026), with the treatment effects on 28-day mortality numerically favoring vitamin C among patients without septic shock (15.4% vs 34%) and numerically favoring placebo among those with septic shock (38.7% vs 29%). Hypernatremia occurred more frequently in the vitamin C group (40/114 [35.1%] vs 24/117 [20.5%]; p = 0.02). Exploratory restricted cubic spline analyses showed that increasing lactate levels were associated with a progressive shift in treatment effect from potential benefit toward potential harm. Post hoc Bayesian analyses further provided probabilistic characterization of the potential treatment effect according to septic shock status. The results of this trial do not support the routine use of megadose vitamin C to reduce 28-day mortality in patients with sepsis. Treatment effects may vary according to septic shock status. This trial was registered with ClinicalTrials.gov on 3 January 2022 (identifier: NCT05194189).

PMID 43053147
阅读全文 →
PubMedNaunyn-Schmiedeberg's archives of pharmacology2026-11-19

Protective effects of intermittent fasting and vitamin E against hyperthyroidism-associated ocular complications in Wistar rats.

Kumar Nirdesh N, Kumari Nidhi N, Singh Geeta G, Singh Beyant B et al.

Our study endeavours to prevent hyperthyroidism-associated ocular complications through the synergy of intermittent fasting and vitamin E supplementation. Our aim was to reduce the incidence of hyperthyroidism-associated ocular complications by combining these two interventions, while carefully monitoring dietary intake and supplementing with vitamin E. In this experiment, animals were divided into normal, hyperthyroidism control, dual, vitamin E, and intermittent fasting groups. Hyperthyroidism was induced by administering thyroxine for 24 days. Animals in the treatment groups took vitamin E and practised intermittent fasting. Intraocular pressure was measured weekly during the protocol. After the protocol, antioxidant status, malondialdehyde and nitrite level, protein content, retinal pictures, histopathology of lens and thyroid profile were analysed. Rats with hyperthyroidism control exhibited elevated (p < 0.001) intraocular pressure, lipid peroxidation, total protein content, and thyroid hormone levels, while antioxidant and nitrite levels decreased (p < 0.001). However, our non-drug therapy significantly (p < 0.001) improved all of these parameters, bringing them to their optimum levels. Intermittent fasting prevented ocular disease caused by hyperthyroidism by reducing oxidative stress and fibro genic matter deposition, and modulating nitrite balance. It works best when combined with vitamin E for superior antioxidant benefits. Our proposed remedies not only improved ocular function but also provided physiological benefits, suggesting a link to metabolic, ophthalmic, and neurogenic diseases in future projections.

PMID 43052389
阅读全文 →
PubMedInsect science2026-11-19

The miR-11-3p/SNF axis modulates diet-responsive plasticity in larval molt number in Bombyx mori.

Sun Xiaoning X, Jiang Yanhong Y, Zhang Yi Y, Dai Taiming T et al.

Developmental plasticity enables insects to modify their developmental trajectories in response to environmental fluctuations. Here, we investigated diet-responsive plasticity in larval molt number, or moltinism, using the trimolter (3M) mutant SMJ (Short-instar Millet-yellow Jiangsu) of Bombyx mori. Stage-restricted feeding with old mulberry leaves increased the tetramolter (4M) proportion in SMJ and identified the second larval instar as a major period of dietary sensitivity. Transcriptomic and endocrine analyses revealed differences in cuticle formation and hormone-related processes in SMJ relative to its 4M parent MJ (Millet-yellow Jiangsu). Stage-matched endocrine profiling further showed that key events in the prothoracicotropic hormone-20-hydroxyecdysone axis and juvenile hormone-related processes occurred later in SMJ than in MJ. In SMJ, sustained hormonal perturbation during the second and third larval instars increased the 4M proportion, supporting a link between endocrine timing and moltinism plasticity. Using a robust model of calcium carbonate-induced moltinism shift, midgut small RNA sequencing identified miR-11-3p as a candidate regulator of diet-responsive plasticity in moltinism. Treatment with a miR-11-3p mimic markedly increased the 4M proportion in SMJ, whereas miR-11 knockout increased the 3M proportion in the 4M DaZao background under inductive conditions. Target prediction followed by expression and functional screening prioritized SNF (encoding U1 small nuclear ribonucleoprotein A), whose direct targeting by miR-11-3p was validated by dual-luciferase reporter assays; SNF knockdown phenocopied miR-11-3p mimic treatment by increasing the 4M proportion. Collectively, these findings identify the miR-11-3p/SNF axis as a post-transcriptional regulator that links dietary cues to plasticity in larval molt number.

PMID 43053477
阅读全文 →
PubMedJournal of medical case reports2026-11-19

Rapid progression of myocardial calcification in a patient presenting with hypercalcemia of unidentified etiology: a case report.

Hirai Shota S, Nishigaito Toshiya T, Mitsumoto Kensuke K, Mizumoto Aya A et al.

Myocardial calcification is an uncommon but clinically important finding that may result in severe cardiac dysfunction. It is generally classified as metastatic calcification triggered by an elevated serum calcium-phosphate product or dystrophic calcification occurring at sites of prior inflammatory or ischemic injury. There are few reports describing dynamic changes in myocardial calcification among patients with hypercalcemia. In addition, hypercalcemia with an unidentified cause has rarely been reported. We encountered a fatal case that developed both metastatic and dystrophic myocardial calcification. This case may contribute to a better understanding of the potential cardiac complications of severe hypercalcemia.Affiliations: Journal instruction requires a city and country for affiliations; however, these are missing in affiliation [2, 3]. Please verify if the provided city and country are correct and amend if necessary.All authors' affiliation addresses are Osaka, Japan. A 57-year-old Japanese woman with a history of asthma presented with nausea and fatigue. She had severe hypercalcemia with acute kidney injury and marked eosinophilia. Intact parathyroid hormone was suppressed (11 pg/mL), with normal parathyroid hormone-related protein and vitamin D metabolites. Fractional excretion of calcium was elevated to 12%. Imaging studies, bone marrow examination, and renal biopsy did not identify a definitive etiology. She was diagnosed with severe hypercalcemia of unidentified etiology complicated by acute kidney injury and eosinophilia. Despite intravenous fluids, calcitonin, and denosumab followed by hemodialysis, she developed progressive respiratory failure and circulatory collapse with myocardial injury and coronary microvascular dysfunction, and serial CT showed new myocardial calcification from day 9 with rapid diffuse progression. She died 22 days after admission despite extracorporeal circulatory support, and autopsy revealed extensive multi-organ calcification including the heart and lungs. Severe hypercalcemia of unidentified etiology can be complicated by extensive myocardial calcification. Ectopic calcification initially induced by hypercalcemia may have been influenced by inflammatory conditions such as eosinophilia. In addition, subsequent myocardial injury may accelerate dystrophic calcification. Clinicians should be aware of the risk of early and progressive cardiac involvement in patients with hypercalcemia, particularly in the presence of inflammatory conditions.

PMID 43053195
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多calcium carbonate + vitamin D3